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Abstract
Energy storage and growth are coordinated in response to nutrient
status of animals. How nutrient-regulated signaling pathways
control these processes in vivo remains insufficiently understood.
Here, we establish an atypical MAP kinase, ERK7, as an inhibitor of
adiposity and growth in Drosophila. ERK7 mutant larvae display
elevated triacylglycerol (TAG) stores and accelerated growth rate,
while overexpressed ERK7 is sufficient to inhibit lipid storage and
growth. ERK7 expression is elevated upon fasting and ERK7 mutant
larvae display impaired survival during nutrient deprivation. ERK7
acts in the fat body, the insect counterpart of liver and adipose
tissue, where it controls the subcellular localization of chromatin-
binding protein PWP1, a growth-promoting downstream effector
of mTOR. PWP1 maintains the expression of sugarbabe, encoding a
lipogenic Gli-similar family transcription factor. Both PWP1 and
Sugarbabe are necessary for the increased growth and adiposity
phenotypes of ERK7 loss-of-function animals. In conclusion, ERK7
is an anti-anabolic kinase that inhibits lipid storage and growth
while promoting survival on fasting conditions.
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Introduction
Animals live in changing nutrient landscape and are competing on
limited nutrient resources. These conditions set requirements for
robust physiological control, allowing efficient growth and energy
storage on abundant nutrition and rapid attenuation of anabolic
processes upon nutrient deprivation. How metabolic pathway activi-
ties are controlled in peripheral tissues of animals to achieve coordi-
nated control of growth and energy storage, remains insufficiently
understood. The fat body (functional counterpart of mammalian liver
and adipose tissue) has emerged as a key coordinator of growth
signaling in Drosophila (Boulan et al, 2015) along with its essential
role as a lipid synthesis and storage organ (Heier & Kuhnlein, 2018).
Thus, it is a signaling hub for nutrient-dependent homeostatic control.
Nutrient-responsive physiological control relies on nutrient-sens-
ing signaling pathways and gene regulatory networks, which
respond to specific groups of macronutrients and drive anabolic
processes upon high nutrient intake. For example, amino acid-
responsive mTOR complex 1 (mTORC1) promotes protein and lipid
biosynthesis and is a major driver of organismal growth (Oldham
et al, 2000; Zhang et al, 2000; Colombani et al, 2003; Porstmann
et al, 2008; Saxton & Sabatini, 2017). A key target process for
mTORC1-dependent growth control is ribosome biogenesis (Mayer
et al, 2004; Grewal et al, 2007; Teleman et al, 2008; Marshall et al,
2012). We recently identified chromatin-binding protein PWP1 as an
mTORC1-dependent regulator of growth through its function as a
positive regulator of RNA polymerase I- and III-mediated ribosomal
RNA (rRNA) expression (Liu et al, 2017; Liu et al, 2018). Inhibition
of rRNA expression in the fat body, either by nutrient deprivation or
genetically, leads to prominent growth inhibition (Grewal et al,
2007; Marshall et al, 2012; Liu et al, 2017). Intracellular sugars are
sensed by a conserved transcription factor (TF) heterodimer Mondo-
Mlx, which promotes de novo lipogenesis in the fat body by activa-
tion of lipid biosynthetic genes (Sassu et al, 2012; Havula et al, 2013;
Musselman et al, 2013; Mattila et al, 2015). In addition to direct regu-
lation of metabolic genes, Mondo-Mlx controls downstream TFs,
such as Gli-similar 2 ortholog Sugarbabe, which acts as a feed-
forward activator of lipid biosynthesis upon sustained sugar feeding
(Mattila et al, 2015; Luis et al, 2016). The anabolic nutrient-sensing
pathways are counterbalanced by anti-anabolic kinases, including
the AMP-activated protein kinase (AMPK) (Herzig & Shaw, 2018).
Drosophila AMPK is necessary for larval growth and adiposity by
affecting visceral muscle function and food intake, rather than acting
tissue autonomously in the fat body (Bland et al, 2010). This implies
that other anti-anabolic kinases might be involved in fat body-medi-
ated homeostatic control during the growth phase of the animal.
ERK7 [also known as ERK8, MAPK15 (Coulombe & Meloche,
2007)] is an atypical MAP kinase implicated in a number of cellular
processes, including proliferation (Iavarone et al, 2006; Xu et al,
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2010; Chia et al, 2014; Colecchia et al, 2015; Jin et al, 2015; Rossi
et al, 2016), secretion (Zacharogianni et al, 2011; Hasygar &
Hietakangas, 2014), and genomic integrity (Groehler & Lannigan,
2010; Cerone et al, 2011; Rossi et al, 2016). Moreover, several inde-
pendent lines of evidence suggest a putative role for ERK7 in nutri-
ent-responsive homeostatic control. Studies in cultured Drosophila
and mammalian cells have shown upregulation of ERK7 protein
expression upon amino acid deprivation (Zacharogianni et al, 2011;
Colecchia et al, 2012). Upregulation of ERK7 expression leads to
kinase autoactivation, as ERK7 lacks the upstream activating kinases
of canonical MAPK pathways (Abe et al, 2001; Klevernic et al, 2006).
ERK7 activation in cultured mammalian cells promotes macroau-
tophagy, an adaptive mechanism to amino acid shortage to restore
cellular amino acid pools (Colecchia et al, 2012; Colecchia et al,
2018). Our earlier study showed fasting-induced upregulation of erk7
gene expression in the insulin-producing cells (IPCs) of Drosophila
larvae (Hasygar & Hietakangas, 2014). Activation of ERK7 in the IPCs
suppresses secretion of insulin-like peptides leading to inhibition of
larval growth, a response observed upon nutrient deprivation (Hasy-
gar & Hietakangas, 2014). Moreover, genome-wide association stud-
ies (GWAS) have suggested that variants of the human ortholog of
ERK7 are associated with obesity (Li et al, 2012). Despite these pieces
of evidence pointing to a role for ERK7 in nutrient signaling, its physi-
ological role in metabolic control has not been previously addressed.
Here, we provide evidence that ERK7 acts as an anti-anabolic
regulator in vivo by inhibiting lipid storage and growth in Droso-
phila larvae. ERK7 acts tissue autonomously in the fat body, where
it counteracts the downstream effectors of major anabolic nutrient
sensors, mTOR and Mondo-Mlx. Specifically, ERK7 regulates the
subcellular localization of chromatin-binding protein PWP1 and,
consequently, downregulates the expression of the lipogenic TF
gene sugarbabe. Through these downstream effectors, ERK7 down-
regulates anabolic processes that promote lipid storage and growth.
Results
ERK7 inhibits lipid storage in the fat body
In order to explore the physiological role of ERK7, we used Crispr/
Cas9 to generate a null mutant Drosophila allele, ERK71 (Figs 1A
and EV1A). Another line, which underwent the same screening
process, but did not contain any mutations in the ERK7 gene, was
used as control. ERK71 animals were viable with no obvious
morphological defects, but mutant males were fully infertile
(Fig EV1B). Experiments with stage and density-controlled larvae
showed that ERK71 mutants displayed significantly elevated triacyl-
glycerol (TAG) levels (Fig 1B). To test if ERK7 regulates lipid stor-
age tissue autonomously, we used fat body-specific (CG-GAL4)
depletion of ERK7 by two independent RNAi lines, which pheno-
copied the ERK71 mutant (Figs 1C and EV2A). In line with the TAG
measurements, ERK71 mutant fat body cells contained significantly
higher numbers of lipid droplets when compared to control tissue,
while the mean size of the droplets was not affected (Figs 1D and E,
and EV2B). To assess the specific impact of ERK7 on lipid storage,
we performed lipidomic analysis with larvae fed [13C]glucose and
detected the ratio of newly synthesized [13C]TAG or unlabeled TAG
to phosphatidylethanolamine (PE) (i.e., storage lipid/membrane
lipid). These elevated newly synthesized and long-term TAG/PE
ratios observed in the ERK71 mutant fat bodies (Fig 1F) imply speci-
fic increase of lipid storage.
Overexpression of ERK7 in the fat body (CG>ERK7) prominently
(> 35%) reduced whole larval TAG levels (Fig 1G). This phenotype
was dependent on ERK7 kinase activity and phosphorylation as
expression of kinase-dead (K54R) and activation loop phosphoryla-
tion-deficient (T190A/Y192F) ERK7 mutants had no effect on TAG
levels (Fig 1G). GFP-marked ERK7 overexpressing fat body clones
(Fig 1H; marked by a yellow dotted line) displayed significantly
reduced number and size of lipid droplets when compared to the
neighboring control cells (marked by a white dotted line) (Figs 1I
and J, and EV2C). The total lipid droplet area was significantly
reduced by ERK7, even when normalized to cell size (Fig EV2D).
These data demonstrate that ERK7 is sufficient to cell autonomously
inhibit TAG storage. The fat body-specific role of ERK7 was further
supported by the finding that ERK7 gene expression in the fat body is
upregulated upon nutrient deprivation (Fig 1K). In contrast to fat
body, expression of ERK7 in the insulin-producing cells (IPCs) did
not lead to reduced TAG stores, ruling out the involvement of insulin
signaling in the regulation of lipid metabolism in this setting
(Fig EV2E).
To further assess the regulation of lipid metabolism by fat body
ERK7 overexpression, we analyzed the fatty acid compositions of
▸Figure 1. ERK7 inhibits lipid storage in the fat body.A Schematic presentation showing the generation of ERK71 mutants by CRISPR/Cas9 targeting.
B ERK71 mutants have elevated triacylglycerol (TAG) levels (N = 4 replicates of ≥ 10 larvae/ replicate for each genotype).
C Fat body-specific depletion of ERK7 by RNAi (BDSC 56939) leads to increased TAG levels (N = 4 replicates of 10 larvae/replicate for each genotype).
D Representative immunofluorescent images of lipid droplet (LipidTOX) and nuclear (DAPI) staining in control and ERK71 mutant fat bodies of third instar larvae. Scale
bar: 50 µm.
E ERK71 mutant fat body cells contain more lipid droplets than control cells (N = 30 cells for each genotype).
F After fed [13C]glucose, the ERK71 mutant fat bodies display elevated [13C]TAG/PE and unlabeled TAG/PE molar ratios (measured by mass spectrometry-based
lipidomics, N = 3 replicates of 15 fat bodies/replicate, TAG = triacylglycerol, PE = phosphatidylethanolamine)
G ERK7 overexpression in the fat body results in reduced TAG levels, while kinase-dead (K54R) and activation loop phosphorylation-deficient (T190A/Y192F) mutants of
ERK7 do not influence the TAG storage (N = 4 replicates of ≥ 10 larvae/replicate for each genotype).
H–J ERK7 expressing, GFP-marked, fat body clone (H, marked by yellow dotted line; scale bar: 50 µm) contains less (I) and smaller (J) lipid droplets than control cells
(marked by white dotted line), visualized by LipidTOX staining (N = 11 for control and 4 for ERK7 overexpression).
K qRT–PCR-based expression analysis of ERK7 from fat bodies of w1118 larvae upon 6 h starvation. Expression of RP49 was used for normalization (N = 3 replicates of
10 fat bodies/replicate for each genotype).
Data information: N stands for the number of biological replicates. Error bars display standard deviation (SD). ns: not significant, *P < 0.05, **P < 0.01, ***P < 0.001
(Student’s t-test).
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the larval total lipids by gas chromatography–mass spectrometry.
Fat body expression of ERK7 led to a significant reduction in the
proportions of potentially de novo synthesized saturated fatty acids
14:0 and 16:0, which are direct products of fatty acid synthase (de
Renobales & Blomquist, 1984), as well as monounsaturated fatty
acids 16:1n-7 and 18:1n-9, which are formed during elongation and/
or desaturation reactions immediately after synthesis (Fig 2A and
B). In contrast, the proportions of 14:1n-7, 16:1n-9, and 14:1n-9
fatty acid isomers were elevated in CG>ERK7 larvae (Fig 2A and B).
To the best of our knowledge, Drosophila tissues do not have delta-
5 or delta-7 desaturase enzymes, which would be required to
directly synthesize these isomers (Shen et al, 2010; Helmkampf
et al, 2015). Chain shortening by peroxisomal beta oxidation of the
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for fatty acid metabolism in Drosophila (Faust et al, 2014), is the
only documented process to produce the 14:1n-7, 16:1n-9, and
14:1n-9 fatty acid isomers. To directly analyze the activity of lipid
biosynthesis, we fed the larvae with 13C-labeled glucose and
analyzed the incorporation of the labeled carbons into the fat body
TAG pool. Indeed, ERK7 fat body overexpression significantly
reduced the glucose flux into fat body TAG stores (Fig 2C). Consis-
tently, levels of circulating glucose were elevated in the CG>ERK7
larvae and reduced in ERK71 mutants (Fig 2D and E).
To get an unbiased view of ERK7-regulated downstream
processes, we analyzed global gene expression changes in ERK71
mutants during feeding and acute nutrient deprivation. RNAseq
analysis was performed in non-wandering 3rd instar control and
ERK71 mutant larvae that were grown either on regular fly food or
following full fasting for 6 h. For an overview of the impact of ERK7
on fasting-induced gene expression changes, the data were visual-
ized on a four-way plot displaying comparisons of fed vs. fasted




Figure 2. ERK7 overexpression inhibits lipid biosynthesis.
A Fatty acid composition of total lipids in CG>control and CG>ERK7 larvae, measured by gas chromatography (N = 3 replicates of 15 larvae/replicate for each genotype).
B Schematic presentation of biosynthesis of fatty acids and their likely chain shortening by peroxisomal partial b-oxidation.
C Amount of glucose-derived [13C]-labeled carbons incorporated into the TAG pool of control and CG>ERK7 fat bodies (N = 3 replicates of 15 fat bodies/replicate for
each genotype and diet).
D Ectopic ERK7 expression in the fat body results in elevated hemolymph glucose levels (N = 3 replicates of 15 larvae/replicate for each genotype).
E Circulating glucose levels are decreased in ERK71 mutants (N = 4 replicates of 15 larvae/replicate for each genotype).
Data information: N stands for the number of biological replicates. Error bars display standard deviation (SD). *P < 0.05, **P < 0.01, ***P < 0.001 (Student’s
t-test).
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conditions) (Fig 3A). This revealed an inverse correlation between
genes responding to nutrient deprivation and to the loss of ERK7: 30
and 39% of fasting inhibited and activated genes, respectively, were
less regulated in ERK71 mutants (Fig 3B). Gene set enrichment anal-
ysis revealed that ERK7 controls many gene groups involved in
growth and metabolism (Fig 3C). Consistent with the phenotypic
data, the analysis revealed significantly elevated expression of genes
belonging to GO terms “lipid particle” and “regulation of lipid stor-
age” in ERK71 mutants. A number of lipid synthesis and storage-
related genes displayed attenuated downregulation upon fasting in
ERK71 mutants (Fig 3D). Several of these genes, such as seipin,
agpat3, ATPCL, and a lipid chaperone fabp were downregulated
upon ERK7 fat body overexpression in fed animals (Fig 3E). Conver-
sely, fasting-induced upregulation of lipases, such as CG34448 and
Lip4, was attenuated in ERK71 mutants (Fig 3D). Expression of these
genes was upregulated in the ERK7 overexpressing fat bodies of fed
larvae (Fig 3F). Collectively, the ERK7-dependent gene expression
changes are consistent with its observed role as a negative regulator
of lipid storage.
Fat body ERK7 inhibits growth tissue autonomously
and systemically
In parallel to the metabolic phenotypes, we observed that ERK7 also
regulates growth. ERK71 mutant larvae displayed accelerated larval
growth rate, as evidenced by increased body weight at 72 h after
egg deposition (Fig 4A) and earlier pupariation compared to the
control larvae (Fig 4B). No changes in the pupal volume were
observed (Fig EV3A). When animals are fed on a limited nutrient
source, wild-type animals do not grow further in order to preserve
their energy. In contrast, ERK71 mutants failed to cease their growth
upon 24 h of fasting (Fig 4C), which coincided with reduced
survival of ERK71 mutant larvae upon fasting (Fig 4D). Fat body-
specific depletion of ERK7 by two independent RNAi lines also led
to a moderate increase in the larval growth rate (Figs 4E and F, and
EV3B), but had no impact on pupal volume (Fig EV3C), phenocopy-
ing ERK71 mutants. Fat body-specific overexpression of ERK7
(CG>ERK7) led to developmental delay (Fig 4G and H) and substan-
tial (> 20%) reduction of pupal volume (Fig 4I). ERK7 expression in
the fat body inhibited growth to a similar extent as the expression in
the IPCs (Fig EV3D). This growth inhibition required ERK7 kinase
activity and phosphorylation, as evidenced by the observation that
expression of kinase-dead (K54R) and activation loop phosphoryla-
tion-deficient (T190A/Y192F) mutants of ERK7 in the fat body did
not influence growth (Fig 4H and I).
Consistent with the increased growth rate, ERK71 mutant fat
body cells displayed increased nuclear size (Fig 5A and B) as
well as increased relative size of the nucleolus (Fig 5C). To
explore if ERK7 is sufficient to inhibit growth in a cell autono-
mous manner, we induced GFP-marked fat body clones with
ERK7 overexpression. The nuclei of the ERK7-expressing cells
were significantly smaller in size (Fig 5D and E). The ERK7-
expressing clones also displayed a reduced relative size of the
nucleolus (Fig 5F). In line with the impaired growth and reduced
nucleolar size, quantitative RT–PCR analysis showed inhibited
expression of fat body ribosomal RNA products (rRNA) of RNA
polymerases I (Fig 5G) and III (Fig 5H) upon ERK7 fat body
overexpression.
PWP1 is a target of ERK7 involved in lipid homeostasis and
growth control
Our findings on the role of ERK7 in Pol I- and Pol III-mediated
rRNA expression led us to test the possible involvement of chro-
matin-binding protein PWP1, which we have recently identified as
a positive regulator of Pol I and Pol III (Liu et al, 2017; Liu et al,
2018). PWP1 is activated by Insulin/mTOR-mediated phosphoryla-
tion, which can be visualized by using a Phos-tag gel (Liu et al,
2017). Intriguingly, ERK7 co-expression with PWP1 in S2 cells
induced an additional band in the PWP1 Phos-tag blot (Fig 6A, red
arrow), while the Insulin/mTOR-inducible PWP1 phosphorylation
pattern (Fig 6A, dark blue arrows) remained unchanged upon
ERK7 expression. This implies that PWP1 is phosphorylated in an
ERK7-dependent manner, either directly or indirectly. To test if
PWP1 is regulated by ERK7 in vivo, we analyzed PWP1 localiza-
tion, which is known to be regulated by nutrient-responsive cues
(Liu et al, 2017). Interestingly, PWP1 nucleolar localization was
significantly increased in the ERK71 mutant fat bodies (Fig 6B and
C). ERK7-overexpression in the fat body also had a significant
effect on PWP1 subcellular localization. ERK7 expressing clones
exhibited significantly reduced nuclear to cytoplasmic ratio
compared to control cells (Fig 6D and E). Thus, ERK7 is necessary
and sufficient to regulate PWP1 subcellular localization in the fat
body.
While PWP1 is known to regulate growth (Liu et al, 2017), its
possible role in lipid homeostasis has remained unexplored. We
observed that fat body-specific knockdown of PWP1 by CG-GAL4
driver caused a significant reduction in TAG levels (Fig 6F), pheno-
copying ERK7 overexpression. Moreover, genetic epistasis experi-
ment revealed that fat body-specific knockdown of PWP1 strongly
▸Figure 3. ERK7 regulates lipid metabolism gene expression.A Four-way plot (t-statistics) presenting the ERK7-dependent fasting-responsive genes (adj.P.val < 0.05). Dark blue indicates significant in both comparisons; dark
turquoise, significant in one comparison; light turquoise, not significant.
B Venn diagrams of the fasting-downregulated/ERK7-dependent transcriptome (adj.P.val < 0.05) and fasting upregulated/ERK7-dependent transcriptome
(adj.P.val < 0.05).
C Bar plots of selected ERK7-regulated pathways with overrepresentation of significantly changing genes (adj.P.val < 0.05, LFC < 0.5 or LFC > 0.5). The bar plot
shows enrichment (log 10 adj.P.val, generated by R/Bioconductor piano package). Blue color denotes downregulated in mutants and red denotes upregulated in
mutants. G—Gene Ontology (GO), K—KEGG Pathway, R—Reactome Pathway Database.
D Heatmaps displaying expression patterns of selected genes involved in lipid anabolism and lipid catabolism. Color key displays scaled log2 gene expression.
E, F Expression analysis of Seipin, Agpat3, ATPCL, fabp, Lip4, and CG34448 by qRT–PCR. RP49 was used for normalization (N = 3 replicates of ≥10 larvae/replicate for each
genotype).
Data information: N stands for the number of biological replicates. Error bars display standard deviation (SD). *P < 0.05, **P < 0.01, ***P < 0.001 (Student’s t-test).
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suppressed the increase of lipid droplet numbers caused by ERK7
knockdown (Fig 6G and H). Loss of PWP1 also suppressed the
increase of nuclear size by ERK7 RNAi (Fig 6I). These data are
consistent with the conclusion that PWP1 contributes to lipid stor-
age and growth downstream of ERK7.
ERK7 controls lipid storage and growth through the transcription
factor Sugarbabe
Earlier studies have shown the role of Gli-similar 2 transcription






Figure 4. Fat body ERK7 inhibits cell autonomous and systemic growth.
A Weight of control and ERK71 mutant larvae at 72 h after egg deposition (AED) (N = 4 replicates of 12 larvae/replicate for each genotype).
B Pupariation kinetics of control and ERK71 mutants (N = 4 replicates of 30 larvae/replicate for each genotype). P < 0.0001, analyzed by Log-rank test.
C ERK71 mutants fail to suppress growth upon 24 h of starvation (N ≥ 4 replicates of 15 larvae/replicate for each genotype).
D ERK71 mutant larvae (N = 4 replicates of 24 larvae/replicate for each genotype, P < 0.01 analyzed by Log-rank test) are sensitive to nutrient deprivation.
E, F Fat body-specific knockdown of ERK7 by RNAi (BDSC 56939) leads to a moderately accelerated pupariation rate (E, P < 0.001 analyzed by Log-rank test, N = 8
replicates of 30 larvae/replicate for each genotype) and an increase in larval weight at 72 h AED (F, N = 5 replicates of 15 larvae/replicate for each genotype).
G A representative image showing that fat body-specific overexpression of ERK7 by the CG-GAL4 driver (CG>ERK7) impairs larval growth. Scale bar: 0.5 mm.
H Ectopic expression of ERK7 leads to delayed pupariation (P < 0.0001, analyzed by Log-rank test), while kinase-dead (K54R) and activation loop phosphorylation-
deficient (T190A/Y192F) mutants of ERK7 do not influence pupariation rate (N = 4 replicates of 30 larvae/replicate for each genotype).
I In contrast to ERK7 wt, kinase-dead (K54R) and activation loop phosphorylation-deficient (T190A/Y192F) mutants of ERK7 do not influence the pupal volume (N = 4
replicates of 10 pupae/replicate for each genotype).
Data information: N stands for the number of biological replicates. Error bars display standard deviation (SD). **P < 0.01, ***P < 0.001, ns—not significant (Student’s
t-test).
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inhibiting lipid catabolism (Zinke et al, 2002; Mattila et al, 2015;
Luis et al, 2016). Interestingly, sugarbabe expression was signifi-
cantly downregulated in the fat body upon PWP1 depletion
(Fig 7A). Consistently with PWP1 inhibition by ERK7, sugarbabe
expression was also strongly downregulated by ectopic fat body
expression of ERK7 (Fig 7B). Moreover, sugarbabe expression was
elevated in ERK71 mutants (Fig 7C). Genetic epistasis experiments
were performed to test whether changes in Sugarbabe levels contri-
bute to the phenotypes caused by ERK7. Hypomorphic sugarbabe
mutant in trans with a deficiency (sug17D/Df(2R)Exel7123)
suppressed the elevated lipid droplet numbers in ERK71 mutants
(Fig 7D and E). Moreover, Sugarbabe overexpression partially
rescued the TAG levels in the CG>ERK7 larvae (Fig 7F). The
observed rescue was not due to impaired ERK7 expression in the
double transgenic lines (Fig EV4A and B). Thus, Sugarbabe acts
downstream of ERK7 to control lipid metabolism.
Interestingly, the sugarbabe mutant also suppressed the elevated
nuclear size in ERK71 mutants (Fig 7G). Moreover, Sugarbabe over-
expression significantly suppressed the developmental delay
(Fig 7H) and pupal volume phenotypes caused by ERK7 overexpres-
sion (Fig 7I). Sugarbabe expression is strongly elevated upon sugar





Figure 5. ERK7 regulates nucleolar size and ribosome biogenesis.
A Representative immunofluorescent images of control and ERK71 mutant fat bodies with DAPI staining to visualize nucleus. Scale bar: 30 µm.
B, C ERK71 mutant fat bodies display increased nuclear area (B, N > 160 cells, obtained from 5 independent fat bodies) and increased nucleolar/nuclear area ratio (C,
N > 80 cells for nucleolus/nucleus ratio, obtained from 5 independent fat bodies), when compared to control fat bodies.
D–F ERK7 expressing fat body clones (D, marked by GFP, scale bar: 20 µm) display reduced nuclear area (E) and reduced nucleolar/nuclear area ratio (F), when
compared to control cells. Nuclei were visualized by DAPI staining, nucleoli were visualized by anti-fibrillarin antibodies (N = 10).
G, H Expression analysis of Pol I (G) and Pol III (H) target RNAs by qRT–PCR. Expression of CDK7 was used for normalization (N = 3 replicates of 10 fat bodies/replicate
for each genotype).
Data information: N stands for the number of biological replicates. Error bars display standard deviation (SD). *P < 0.05, **P < 0.01, ***P < 0.001, ns—not significant
(Student’s t-test).
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Figure 6. PWP1 acts downstream of ERK7 to control growth and lipid storage.
A ERK7 overexpression leads to phosphorylation of PWP1, as shown by appearance of an extra band on Phos-tag Western blot (marked with red arrow). Insulin-
inducible bands (dark blue arrows) remain unresponsive to ERK7.
B Representative immunofluorescent images of PWP1 localization in fat bodies of ERK71 mutant and control third instar larvae. Scale bar: 20 µm.
C PWP1 localization displays increased nucleolar/nuclear ratio in ERK71 mutant fat bodies compared to control (N = 20 cells from 5 independent fat bodies per
genotype).
D Representative immunofluorescent images of PWP1 localization in fat bodies of third instar larvae. ERK7 overexpression (GFP-marked clones) alters the subcellular
localization of PWP1. Scale bar: 30 µm.
E PWP1 localization displays reduced nuclear/cytoplasmic ratio in ERK7 overexpressing clones, compared to control cells (N = 10 cells from at least 8 different fat
bodies per genotype).
F Fat body-specific depletion of PWP1 by RNAi (NIG-Fly 6751R-3) leads to decreased TAG levels (N = 4 replicates of ≥ 10 larvae/replicate for each genotype).
G Representative immunofluorescent images of fat bodies in a genetic epistasis experiment using ERK7 and PWP1 fat body (CG-GAL4) knockdown with LipidTOX
staining and DAPI to visualize lipid droplets and nucleus, respectively. Scale bar: 50 µm.
H, I Fat body-specific knockdown of PWP1 (NIG-Fly 6751R-1) suppresses increased lipid droplet number (H; N > 30 cells per genotype) and increased nuclear area (I;
N > 45 cells per genotype) caused by ERK7 knockdown (BDSC 56939).
Data information: N stands for the number of biological replicates. Error bars display standard deviation (SD). **P < 0.01, ***P < 0.001 (Student’s t-test).
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if the growth impairment of fat body-specific ERK7 expressing
larvae could be rescued by dietary sugar. CG>ERK7 larvae survived
very poorly on 20% yeast food, displaying only 30% pupariation
rate and prominent developmental delay (Fig 7J). Strikingly, the
addition of 20% sugar to the 20% yeast food significantly improved
survival and developmental rates in the CG>ERK7 larvae (Fig 7J).
We confirmed that sugar feeding led to a significant increase in
sugarbabe expression levels in CG>ERK7 larvae (Fig EV4C). Thus,
Sugarbabe also contributes to growth control downstream of ERK7,
further highlighting the coordinated control of growth and lipid stor-
age by ERK7.
Discussion
Our study uncovered a new regulatory mechanism of lipid metabo-
lism and growth in vivo. We report that an atypical MAP kinase
ERK7 inhibits lipid storage and cell growth in the Drosophila
fat body. ERK7 expression is upregulated by fasting and it
contributes to the physiological adaptation to nutrient shortage.
Mechanistically, ERK7 regulates the subcellular localization of the
chromatin-binding protein PWP1 and inhibits the expression of the
transcription factor, Sugarbabe. By regulating these downstream
effectors, ERK7 counteracts the output of anabolic nutrient sensors
mTORC1 and Mondo-Mlx.
While several functions have been assigned to ERK7 in cultured
cells (Iavarone et al, 2006; Groehler & Lannigan, 2010; Xu et al,
2010; Cerone et al, 2011; Zacharogianni et al, 2011; Colecchia et al,
2012; Chia et al, 2014; Colecchia et al, 2015; Jin et al, 2015; Rossi
et al, 2016; Colecchia et al, 2018), our understanding of its physio-
logical role has remained limited. We discovered that, in addition to
inhibitory role in the IPCs (Hasygar & Hietakangas, 2014), ERK7 has
an important regulatory role in the fat body, where it inhibited both
cell autonomous and organismal growth. Fat body ERK7 was suffi-
cient to inhibit rRNA expression, which is a well-established mecha-
nism for nutrient-dependent growth control. Notably, inhibition of
ribosome assembly in the IPCs (e.g., by inhibition of Rio kinases)
led to ERK7 upregulation (Hasygar & Hietakangas, 2014), implying
that ERK7 may have a role as a feedback regulator of ribosome
biogenesis. Human ortholog of ERK7, MAPK15/ERK8, was earlier
shown to promote autophagy (Colecchia et al, 2012), which
together with ribosome biogenesis, controls cellular amino acid
balance. As mTOR signaling inhibits autophagy and activates ribo-
some biogenesis (Scott et al, 2004; Grewal et al, 2007), ERK7
appears to counteract these key downstream effects of the mTOR
pathway. A recently established regulator of ribosome biogenesis
and growth, PWP1, was identified as a downstream target for ERK7
signaling. ERK7 expression induced phosphorylation of PWP1
detected by Phos-tag gel, while having no influence on the Insulin/
mTORC1-dependent bands. This suggests that ERK7 controls PWP1
in parallel, rather than upstream, of mTORC1. ERK7 activity in the
fat body cells caused a prominent change in PWP1 subcellular local-
ization. While loss of ERK7 increased PWP1 localization in the
nucleolus, ERK7 overexpression led to increased cytoplasmic local-
ization. We have previously shown that nucleolar PWP1 is lost
upon inhibition of mTOR (Liu et al, 2017). Our present observations
of the regulation of PWP1 phosphorylation and subcellular localiza-
tion by ERK7 further highlight the role of PWP1 as a downstream
effector of nutrient-responsive signaling pathways.
The human ortholog of ERK7, MAPK15, is associated with
obesity (Li et al, 2012). However, the functional role of ERK7 in
energy metabolism of animals has not been previously addressed.
Here, we observed that ERK7 has an antiadipogenic role in Droso-
phila. Several lines of evidence imply that ERK7 inhibits lipid meta-
bolism and storage tissue autonomously in the fat body. Firstly,
ERK7 overexpression in the fat body clones results in smaller and
fewer lipid droplets, while ERK7 mutant fat bodies possess elevated
number of lipid droplets per cell. Secondly, fat body-specific expres-
sion of ERK7 inhibits the flux of glucose-derived carbon into the
TAG pool. Thirdly, in a genome-wide expression analysis, ERK7
mutants displayed deregulated expression of genes involved in lipid
synthesis, storage, and catabolism. Our genetic epistasis experi-
ments further revealed that the lipid storage phenotypes are depen-
dent on the Gli-similar transcription factor Sugarbabe, whose
expression is inhibited by ERK7. We found that sugarbabe expres-
sion was downregulated by the inhibition of PWP1, a downstream
target of ERK7. Consistently, PWP1 was necessary for lipid storage
downstream of ERK7, thus broadening the role of PWP1 as an
anabolic regulator in vivo. Previous studies have shown that sugar-
babe is one of the most strongly sugar-responsive genes in Droso-
phila (Zinke et al, 2002; Mattila et al, 2015). It is a direct target of
the sugar-sensing transcription factor complex Mondo-Mlx and its
expression is also promoted by the Dawdle-induced TGF-beta/
Activin signaling pathway, which signals through the transcription
▸Figure 7. Sugarbabe is a downstream effector of ERK7 and PWP1.A, B Expression of sugarbabe is downregulated in fat bodies upon knockdown of PWP1 (A) and ectopic expression of ERK7 (B) (N = 3 replicates of 10 fat bodies/replicate
for each genotype).
C ERK71 mutants fail to maximally downregulate sugarbabe expression upon fasting (N = 4 replicates of 10 larvae/replicate for each genotype).
D Representative immunofluorescent images of fat bodies in a genetic epistasis experiment using ERK71 and sug mutants (sug17D/Df(2R)Exel7123) with LipidTOX and
DAPI staining to visualize lipid droplets and nucleus, respectively. Scale bar: 50 µm.
E sug mutant (sug17D/Df(2R)Exel7123) suppresses increased lipid droplet number observed in ERK71 mutants (N > 20).
F Ectopic sugarbabe expression in the fat body partially rescues TAG levels in the CG>ERK7 larvae (N = 4 replicates of ≥10 larvae/replicate for each genotype).
G sug mutant (sug17D/Df(2R)Exel7123) suppresses increased nuclear size phenotype of ERK71 mutant fat body cells (N ≥ 25 cells per genotype).
H, I Ectopic Sugarbabe expression in the fat body partially restores the pupariation rate (H) (P < 0.001 for the rescue, analyzed by Log-rank test, N = 4 replicates of 30
larvae/replicate for each genotype) and pupal volume of CG>ERK7 larvae (I) (N = 4 replicates of 10 pupae/replicate for each genotype).
J Addition of 20% sucrose improves the growth rate and survival of CG>ERK7 larvae. Pupariation kinetics of CG>ERK7 larvae on 20% yeast or 20% yeast + 20%
sucrose diet (P < 0.0001 for the rescue, analyzed by Log-rank test, N = 4 replicates of 30 larvae/replicate for each genotype and diet).
Data information: N stands for the number of biological replicates. Error bars display standard deviation (SD). *P < 0.05, **P < 0.01, ***P < 0.001 (Student’s t-test).
Expression of RP49 was used for normalization of (A–C).
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factor SMAD2 (Mattila et al, 2015). Thus, Sugarbabe regulation
converges several nutrient-dependent inputs to control lipid metabo-
lism. Notably, we also discovered that Sugarbabe was necessary
and sufficient to control growth downstream of ERK7, both at the
level of individual cells as well as the whole organism. This high-
lights that the regulation of fat body lipid homeostasis is closely
coupled to growth control.
Wild Drosophila melanogaster larvae face competition against
their peers and the micro-organisms fermenting their nutrient
source. Therefore, there is a selective advantage to be gained by fast
larval development without compromising body size, such as that
observed in the ERK7 mutants. However, such rapid growth on a
rich diet comes with a cost, as tolerance to fasting was compromised
in the ERK7 mutants. Recent studies have shown macronutrient-
dependent differences in larval performance between closely related
Drosophila species. For example, D. simulans larvae develop signifi-
cantly better on a high sugar diet than its specialist relative D. sechel-
lia, which outperforms D. simulans on limited nutrition (Melvin
et al, 2018). Similarly, D. biarmipes, which feeds on rotting fruit with
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higher protein levels than D. suzukii, which colonizes fruit that is still
ripe (Silva-Soares et al, 2017). It will be interesting to explore whether
natural variation in the ERK7 gene contributes to animal adaptation
to habitats with distinct nutrient availabilities.
Materials and Methods
Fly stocks and husbandry
Flies were maintained at 25°C in a 12-h light/12-h dark cycle,
on standard Drosophila medium (agar 0.6% (w/v), semolina
3.2% (w/v), malt 6.5% (w/v), dry baker’s yeast 1.8% (w/v),
propionic acid 0.7% (v/v), and Nipagin (methylparaben) 2.4%
(v/v). Driver lines used: dILP2-Gal4, UAS-GFP (Rulifson et al,
2002), CG-Gal4 (Hennig et al, 2006). w1118 crossed to the respec-
tive Gal4-lines were used as controls. Stocks used included: UAS-
ERK7 (Hasygar & Hietakangas, 2014), UAS-ERK7-RNAi (BDSC
56939, VDRC v109661), UAS-Sug (FlyORF F000721), UAS-PWP1-
RNAi (NIG-Fly 6751R-3, NIG-Fly 6751R-1), and Actin<CD2<GAL4
GFPnls. To generate mosaic clones, larvae (genotype: HsFLP/+;
UAS-ERK7/+; Actin<CD2<Gal4 GFPnls/+) were heat-shocked at
37°C for 60 min at 24 h after egg laying. Sug17D mutant was used
in trans with a deficiency Df(2R)Exel7123 as described in (Mattila
et al, 2015).
Generation of kinase defective ERK7 overexpression flies: ERK7
K54R and ERK7 T190A/Y192F cDNA were amplified by PCR
from pMT-ERK7K54R-V5-His and pMT-ERK7T190A/Y192F-V5-His
(Zacharogianni et al, 2011), cloned into the pUAST-attB vector and
confirmed by sequencing. Both the transgenes were directed to the
attP landing site at 22A2, similar to the wt ERK7. Transgenic flies
were constructed by BestGene Inc.
CRISPR/Cas9-mediated mutagenesis of the ERK7 gene
ERK7 mutant flies were generated using the CRISPR/Cas9 (Kondo &
Ueda, 2013). The following sgRNA sequence was used: TGCCTATGG-
CATCGTCTGGAAGG. Embryo injections were carried out by Bestgene
Inc. Progeny was screened for the mutations using T7 Endonuclease I
(NEB) assay (Vouillot et al, 2015). One mutant line was identified
(ERK71) which was further confirmed by direct sequencing of the
target region. ERK71 line was found to contain a deletion of 10 nucleo-
tides (CDS: 111 – 120, CATCGTCTGG). The deletion also resulted in a
frameshift and introduced a premature stop codon after 48 amino
acids. This deletion disrupted the open reading frame and led to a
severely truncated polypeptide (48 AA) lacking the predicted ATP
binding site as well as the activation loop (Abe et al, 1999; Marchler-
Bauer & Bryant, 2004). The first alternate in-frame ATG sequence
downstream of the mutated site encodes methionine 107. Should that
codon be utilized as a start codon in the mutant, the resulting polypep-
tide would lack major parts of the kinase domain, including the
predicted active site, ATP binding site, and polypeptide substrate bind-
ing site. Thereby, we conclude that ERK71 is a likely null allele.
Another line, which underwent the same screening process, but did
not contain any mutations in the ERK7 gene, was used as control.
ERK71 and control lines were backcrossed into w1118 genetic back-
ground (VDRC 60000) for five generations and maintained as
balanced stocks.
Fertility assay
Ten male flies from control or ERK71 lines were crossed with ten
w1118 females in four replicates and were allowed to lay eggs for
3 days on standard laboratory food. Total number of adults hatched
was counted after 18 days.
Fasting conditions
Larvae: Equal number (30/vial) of freshly hatched L1 larvae was
grown on standard laboratory food for 2 days. Early 3rd instar larvae
(72 h AED, pre-critical weight) were transferred to 48-well plates (1
larva/well) containing PBS + 0.5% agar + 0.2% Erioglaucine dye (Dr.
Oetker). The number of surviving larvae was counted every 24 h.
RNA sequencing
Freshly hatched L1 larvae were grown at equal density (30/vial) on
standard Drosophila medium. Third instar larvae (90 h AED) were
transferred to starvation medium (PBS + 0.5% agarose) for 6 h.
Total RNA was isolated from both fed and starved male larvae (con-
trol and ERK71) using Nucleospin RNA II kit (Macherey-Nagel).
Transcriptome sequencing (RNAseq) was performed with Illumina
NextSeq500 technology to an average depth of 20 M clean reads
per sample.
Bioinformatic analysis of RNAseq data
FastQC v.0.11.2 was used for quality assessment and Trimmomatic
v.0.33 for trimming the data. The minimum read length of 36 bases
was required. Minimum read quality score of 20 was used. The
reads were scanned with 4-base sliding window and trimmed when
the average quality per base dropped below 15. The reads were
mapped with TopHat (v.2.1.0) to the D. melanogaster reference
genome (FlyBase R6.10). Transcription was quantified strand-specif-
ically with HTSeq (v.2.7.6) on the level of annotated exons (Fly-
base) with reads below quality score of 10 discarded. The
differential expression among different samples and conditions was
quantified with limma package (v.3.28.8) implemented in R/Biocon-
ductor with Benjamini–Hochberg correction. The genes with very
low counts (cpm < 1 in more than one replicate per condition)
were filtered.
Gene set enrichment analysis
Gene set enrichment analysis was performed with R/Bioconductor
package piano (v.1.12.1) for significant genes (Control starved vs.
ERK71 mutants starved, adj.P.val < 0.05) with t-statistics by using
gsa with gsea algorithm and row sampling (1,000 permutations).
The manually downloaded databases consisted of KEGG, Reactome,
Wikipathways, and GO.
RNA extraction and quantitative RT–PCR
RNA extraction from larval fat bodies: 10 fat bodies from stage-
matched third instar non-wandering larvae were dissected and RNA
was extracted using Nucleospin RNA XS kit (Macherey-Nagel)
according to the manufacturer’s protocol.
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RNA extraction from whole larvae: Five stage-matched third
instar non-wandering larvae were homogenized and RNA was
extracted using Nucleospin RNA II kit (Macherey-Nagel) according
to the manufacturer’s protocol. Equal amount of RNA was used for
reverse transcription (RevertAid H Minus First Strand cDNA Synthe-
sis Kit, Thermo Scientific). qRT–PCR was performed with Light
cycler 480 Real-Time PCR System (Roche) using Maxima SYBR
Green qPCR Master Mix (2×) (Fermentas). At least three biological
replicates were used for each genotype and at least three technical
replicates were used for each biological replicate. Primer sequences
are available upon request.
Metabolite assays
Metabolite assays were performed from pre-wandering 3rd instar
larvae. All analyses were done at least in three biological repli-
cates. Freshly hatched 1st instar larvae were grown at controlled
density (30/vial) on standard Drosophila medium. Samples were
extracted from pre-wandering 3rd instar larvae (90–96 h) and TAG
assays were conducted using the coupled colorimetric assay
(Triglyceride Reagent—Sigma; 82449, Free Glycerol Reagent—
Sigma; F6428) and normalized to body weight as described previ-
ously (Tennessen et al, 2014). Hemolymph from third instar larvae
was extracted as described previously (Zhang et al, 2011) and the
circulating glucose was measured with the Glucose HK assay
reagent (Sigma; GAHK-20) as described elsewhere (Tennessen
et al, 2014).
Fatty acid analysis by gas chromatography–mass spectrometry
Frozen third instar larvae were homogenized in 1% sulfuric acid in
methanol and transmethylated by heating under nitrogen atmo-
sphere (using hexane as cosolvent). The fatty acid methyl esters
(FAME) formed were extracted with hexane in two steps. The dried
and concentrated FAME were analyzed by a Shimadzu GC-2010 Plus
gas chromatograph (Shimadzu, Kyoto, Japan) employing a ZBWAX
capillary column (length 30 m, internal diameter 0.32 mm, film
thickness 0.25 µm; Phenomenex, Torrance, CA, USA) and a flame
ionization detector (FID). For the temperature-programmed runs,
the sample solutions (2 µl) were injected in split mode, and helium
was used as the carrier gas. The integrated and manually corrected
(GCsolution software, Shimadzu) peak areas were converted to mol
% by using the theoretical response factors for FID (Ackman, 1992)
and calibrations with quantitative authentic standards (Supelco,
Bellefonte, PA, USA). The FAME were identified by their mass spec-
tra recorded by using a Schimadzu GCMS-QP2010 Ultra with mass
selective detector (MSD). The results represent the FA composition
of the total lipids.
Lipid labeling and analysis of newly synthesized TAG by
mass spectrometry
Freshly hatched L1 larvae (CG>Control and CG>ERK7) were grown
at equal density (30/vial) on standard Drosophila medium. Early
third instar larvae (72 h AED) were transferred to 10% yeast + 1%
glucose or 10% yeast + 1% [13C]glucose medium for 24 h. A total of
15 fat bodies per replicate were dissected, cellular lipids were
extracted according to the Folch procedure (Folch et al, 1957) and
dissolved in chloroform/methanol 1:2. Immediately before mass
spectrometry, 2% NH4OH was added along with an internal stan-
dard mixture. The samples were injected into a triple quadrupole
mass spectrometer (Agilent 6490 Triple Quad LC/MS with iFunnel
Technology; Agilent Technologies, Santa Clara, CA) at a flow rate
of 10 ll/min, and spectra were recorded. TAGs were detected as
(M + NH4)+ ions (Duffin et al, 1991). Mass spectra were processed
by MassHunter software (Agilent Technologies, Inc. California,
USA) and the intensity proportions from unlabeled and mass-
shifted [13C]TAG ions were resolved by comparing the spectra of
the samples with or without labeling. The total concentrations
relating to the calculated intensity of the labeled (mmol [13C]
TAG produced in the pooled fat body sample in 24 h) and unla-
beled TAG species were quantified against the internal standard
TAG 54:3 (Sigma, T7140 Glyceryl trioleate). PEs were selectively
detected using a head-group specific MS/MS scanning mode for
neutral loss of 141 (NL141) and quantified against internal stan-
dards PE 28:2 and PE 40:2 (both synthesized in-house). To
detect TAG accumulation after and before the 24-h [13C]glucose
feeding, the molar ratios of [13C]TAG/PE and unlabeled TAG/PE
ratios were calculated.
Immunostainings and microscopy
Immunostainings were performed as described previously (Hasy-
gar & Hietakangas, 2014); samples were mounted using Vecta-
shield Mounting Medium with DAPI (Mediq) and imaged using a
Leica TCS SP5 MP SMD FLIM and Leica SP8 Up-right microscopes.
Fluorescence and compartment size (nuclear and nucleolar) were
quantified by ImageJ software (NIH). Antibodies used were as
follows: rabbit anti-PWP1 (Casper et al, 2011), mouse anti-fibril-
larin (Abcam ab4566), anti-rabbit Alexa fluor 568 (Invitrogen),
anti-rabbit Alexa fluor 633 (Invitrogen), and anti-mouse Alexa
fluor 647 (Invitrogen).
LipidTOX staining
Fat bodies from third instar larvae were fixed in 4% formaldehyde
for 30 min, washed thrice with PBS. Fat bodies were stained with
LipidTOX (H34477, Thermo Fisher) 1:400 in PBS, for 30 min at
room temperature, washed thrice with PBS, and mounted using
Vectashield Mounting Medium with DAPI (Mediq). Samples
were imaged using a Leica TCS SP5 MP SMD FLIM and Leica SP8
Up-right microscopes and images were processed using ImageJ
software (NIH).
Image quantification
For lipid droplet analysis, the middle slices were selected from
confocal stacks of fat bodies, and the outlines of the cells were
manually defined. Droplets size and number per cell were identified
by the Analyze Particles function in FIJI (Schindelin et al, 2012).
Quantification of nuclear size was done by manually selecting
outlines of individual cells at their maximum size in FIJI. For
nucleolar size determination, same process was done with a selec-
tion of the maximum nucleolus size of a cell. Mean intensity data
for region of interests were used to quantify subcellular localization
changes of PWP1 detected by immunostaining. While the PWP1
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signal from the whole nucleus was used to quantify the average
immunofluorescence in the nucleus, immunofluorescence from five
cytoplasmic regions within a cell was used to assess the cytoplasmic
PWP1 signal.
Cell culture and transfections
Culturing and transfections of Drosophila S2 cells were performed
as described in (Liu et al, 2017).
Western blotting
Phos-tag SDS–PAGE gels were made according to the manufac-
turer’s protocol using 30 lM phos-tag (Wako Chemical). Samples
were resolved on SDS–PAGE with or without Phos-tag and detected
via Western blotting and bands were quantified using Image studio
lite software (Li-COR).
Pupal volume measurement
Pupal volume was quantified as previously described (Delanoue
et al, 2010).
Statistics
The statistical significances for the survival analysis experiments
and pupariation rate experiments were analyzed by using the Log-
rank test (JMP Pro 13 software). Statistical significances for rest of
the experiments were determined by using unpaired Student’s t-test.
All quantitative data are presented as average  standard deviation.
No outliers were excluded.
Data availability
The RNAseq data is available in GEO, with the accession number:
GSE123901 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE123901).
Expanded View for this article is available online.
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